Superficial siderosis after brachial plexus avulsion KU LeuvenThomas Decramer, Tom Theys, Charlotte Smetcoren, Johan van Loon, Vincent Thijs
CHARCOT-MARIE-TOOTH DISEASE-ASSOCIATED MUTATIONS IN HSPB1 IMPAIRS NORMAL PROTEOLYSIS KU LeuvenL Pottle, C d'Ydewalle, Veronick Benoy, P Van den Berghe, L Van den Bosch
Minute-by-minute monitoring of autoregulation. Response KU LeuvenBart Depreitere, Geert Meyfroidt, Fabian Güiza
SECOND IMMUNOTHERAPY IN PATIENTS WITH HIGH GRADE GLIOMA: IS IT USEFUL? KU LeuvenStefaan Van Gool, Steven De Vleeschouwer
IMMUNOTHERAPY FOR RELAPSED MALIGNANT GLIOMA IN CHILDREN KU LeuvenStefaan Van Gool, Steven De Vleeschouwer
Atlantoaxial instability in monozygotic twin sisters: degenerative or congenital disease? KU LeuvenLars de Jong, Michiel Verfaillie, Steven Pans, Philippe Lauweryns, Jan Goffin, Bart Depreitere
PHARMACOLOGICAL INHIBITION OF HDAC6 IS BENEFICIAL IN A MOUSE MODEL OF DISTAL HEREDITARY MOTOR NEUROPATHY (DISTAL HMN) KU LeuvenVeronick Benoy, C d'Ydewalle, L Van Helleputte, J Krishnan, P Van Damme, J Irobi, AP Kozikowski, V Timmerman, W Robberecht, L Van den Bosch, et al.
VALIDATION OF AN ALLYLGLYCINE MODEL OF PHARMACORESISTANT EPILEPSY IN ZEBRAFISH KU LeuvenCamila Esguerra
IDENTIFICATION OF KINASE INHIBITORS THAT PROTECT AGAINST SEIZURES IN ZEBRAFISH AND RODENT MODELS OF EPILEPSY KU LeuvenCamila Esguerra
STRATIFICATION ACCORDING TO HGG-IMMUNO RPA MODEL PREDICTS OUTCOME IN PATIENTS WITH RELAPSED MALIGNANT GLIOMA TREATED BY ADJUVANT POSTOPERATIVE DC VACCINATION KU LeuvenSteven De Vleeschouwer, Hilko Ardon, Frank Van Calenbergh, Raf Sciot, Guy Wilms, Johan van Loon, Jan Goffin, Stefaan Van Gool